Literature DB >> 11241802

Planning for the next pandemic of influenza.

I D Gust1, A W Hampson, D Lavanchy.   

Abstract

Worldwide influenza pandemics have occurred at irregular and unpredictable intervals throughout history and it is confidently expected that they will continue to occur in the future. It is now recognised that these pandemics result when avian influenza A viruses succeed in adaptation to and transmission between humans. The impact of pandemic influenza is substantial in terms of morbidity, mortality and economic cost and there is the potential for serious social disruption. Influenza vaccines remain the most effective defence against influenza but will be in short supply during a pandemic, as will the new specific anti-influenza drugs, due to the lead-time required for production and rapid spread of the virus. To minimise the impact of pandemics it is imperative to maximise the availability of both vaccines and antivirals and to ensure that they are used optimally. This requires planning at both the international and national levels. The World Health Organization has, therefore, developed a staged plan for responding to a pandemic threat which is based principally on its surveillance program. It has also prepared guidelines to assist national agencies in their planning. However, there may be further options for increasing our preparedness which should also be considered. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241802     DOI: 10.1002/rmv.301

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  8 in total

1.  Developing vaccines against pandemic influenza.

Authors:  J M Wood
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Strategies for improving influenza immunization rates among hard-to-reach populations.

Authors:  David Vlahov; Micaela H Coady; Danielle C Ompad; Sandro Galea
Journal:  J Urban Health       Date:  2007-07       Impact factor: 3.671

3.  Modeling the economic impact of pandemic influenza: a case study in Turkey.

Authors:  Elcin Yoldascan; Behice Kurtaran; Melik Koyuncu; Esra Koyuncu
Journal:  J Med Syst       Date:  2010-04       Impact factor: 4.460

4.  Project VIVA: a multilevel community-based intervention to increase influenza vaccination rates among hard-to-reach populations in New York City.

Authors:  Micaela H Coady; Sandro Galea; Shannon Blaney; Danielle C Ompad; Sarah Sisco; David Vlahov
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

5.  Early vaccine availability represents an important public health advance for the control of pandemic influenza.

Authors:  Amy L Greer
Journal:  BMC Res Notes       Date:  2015-05-08

Review 6.  Pandemic influenza planning, United States, 1978-2008.

Authors:  John Iskander; Raymond A Strikas; Kathleen F Gensheimer; Nancy J Cox; Stephen C Redd
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

7.  The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine.

Authors:  Signe C Svindland; Åsne Jul-Larsen; Rishi Pathirana; Solveig Andersen; Abdullah Madhun; Emanuele Montomoli; Inderjit Jabbal-Gill; Rebecca J Cox
Journal:  Influenza Other Respir Viruses       Date:  2011-07-12       Impact factor: 4.380

8.  Economics of neuraminidase inhibitor stock piling for pandemic influenza, Singapore.

Authors:  Vernon J Lee; Kai Hong Phua; Mark I Chenm; Angela Chow; Stefan Ma; Kee Tai Goh; Yee Sin Leo
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.